BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25271621)

  • 21. On the origin of the cholestenoic acids in human circulation.
    Meaney S; Babiker A; Lütjohann D; Diczfalusy U; Axelson M; Björkhem I
    Steroids; 2003 Sep; 68(7-8):595-601. PubMed ID: 12957664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence of 3 beta-hydroxy-5-cholestenoic acid, 3 beta,7 alpha-dihydroxy-5-cholestenoic acid, and 7 alpha-hydroxy-3-oxo-4-cholestenoic acid as normal constituents in human blood.
    Axelson M; Mörk B; Sjövall J
    J Lipid Res; 1988 May; 29(5):629-41. PubMed ID: 3411238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concentrations of cholestenoic acids in plasma from patients with liver disease.
    Axelson M; Mörk B; Aly A; Wisén O; Sjövall J
    J Lipid Res; 1989 Dec; 30(12):1877-82. PubMed ID: 2621414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concentrations of cholestenoic acids in plasma from patients with reduced intestinal reabsorption of bile acids.
    Axelson M; Mörk B; Aly A; Walldius G; Sjövall J
    J Lipid Res; 1989 Dec; 30(12):1883-7. PubMed ID: 2621415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions.
    Laffitte BA; Joseph SB; Chen M; Castrillo A; Repa J; Wilpitz D; Mangelsdorf D; Tontonoz P
    Mol Cell Biol; 2003 Mar; 23(6):2182-91. PubMed ID: 12612088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5.
    Marelli C; Lamari F; Rainteau D; Lafourcade A; Banneau G; Humbert L; Monin ML; Petit E; Debs R; Castelnovo G; Ollagnon E; Lavie J; Pilliod J; Coupry I; Babin PJ; Guissart C; Benyounes I; Ullmann U; Lesca G; Thauvin-Robinet C; Labauge P; Odent S; Ewenczyk C; Wolf C; Stevanin G; Hajage D; Durr A; Goizet C; Mochel F
    Brain; 2018 Jan; 141(1):72-84. PubMed ID: 29228183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis.
    Theofilopoulos S; Wang Y; Kitambi SS; Sacchetti P; Sousa KM; Bodin K; Kirk J; Saltó C; Gustafsson M; Toledo EM; Karu K; Gustafsson JÅ; Steffensen KR; Ernfors P; Sjövall J; Griffiths WJ; Arenas E
    Nat Chem Biol; 2013 Feb; 9(2):126-33. PubMed ID: 23292650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SPG5 and multiple sclerosis: clinical and genetic overlap?
    Criscuolo C; Carbone R; Lieto M; Peluso S; Guacci A; Filla A; Quarantelli M; Lanzillo R; Morra VB; De Michele G
    Acta Neurol Scand; 2016 Jun; 133(6):410-4. PubMed ID: 26370385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 7-Dehydrocholesterol metabolites produced by sterol 27-hydroxylase (CYP27A1) modulate liver X receptor activity.
    Endo-Umeda K; Yasuda K; Sugita K; Honda A; Ohta M; Ishikawa M; Hashimoto Y; Sakaki T; Makishima M
    J Steroid Biochem Mol Biol; 2014 Mar; 140():7-16. PubMed ID: 24269243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chenodeoxycholic Acid: An Update on Its Therapeutic Applications.
    Fiorucci S; Distrutti E
    Handb Exp Pharmacol; 2019; 256():265-282. PubMed ID: 31267167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of plasma 7alpha-hydroxy-4-cholesten-3-one and 27-hydroxycholesterol concentrations as markers for hepatic bile acid synthesis in cholesterol-fed rabbits.
    Honda A; Yoshida T; Xu G; Matsuzaki Y; Fukushima S; Tanaka N; Doy M; Shefer S; Salen G
    Metabolism; 2004 Jan; 53(1):42-8. PubMed ID: 14681840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholestenoic acid as endogenous epigenetic regulator decreases hepatocyte lipid accumulation in vitro and in vivo.
    Wang Y; Pandak WM; Hylemon PB; Min HK; Min J; Fuchs M; Sanyal AJ; Ren S
    Am J Physiol Gastrointest Liver Physiol; 2024 Feb; 326(2):G147-G162. PubMed ID: 37961761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of LXRs prevents bile acid toxicity and cholestasis in female mice.
    Uppal H; Saini SP; Moschetta A; Mu Y; Zhou J; Gong H; Zhai Y; Ren S; Michalopoulos GK; Mangelsdorf DJ; Xie W
    Hepatology; 2007 Feb; 45(2):422-32. PubMed ID: 17256725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Side chain hydroxylations in bile acid biosynthesis catalyzed by CYP3A are markedly up-regulated in Cyp27-/- mice but not in cerebrotendinous xanthomatosis.
    Honda A; Salen G; Matsuzaki Y; Batta AK; Xu G; Leitersdorf E; Tint GS; Erickson SK; Tanaka N; Shefer S
    J Biol Chem; 2001 Sep; 276(37):34579-85. PubMed ID: 11454857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells.
    Fu X; Menke JG; Chen Y; Zhou G; MacNaul KL; Wright SD; Sparrow CP; Lund EG
    J Biol Chem; 2001 Oct; 276(42):38378-87. PubMed ID: 11504730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis.
    Mignarri A; Magni A; Del Puppo M; Gallus GN; Björkhem I; Federico A; Dotti MT
    J Inherit Metab Dis; 2016 Jan; 39(1):75-83. PubMed ID: 26153518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification of a 3beta-hydroxy-delta5-C27-steroid dehydrogenase from pig liver microsomes active in major and alternative pathways of bile acid biosynthesis.
    Furster C; Zhang J; Toll A
    J Biol Chem; 1996 Aug; 271(34):20903-7. PubMed ID: 8702847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge.
    Björkhem I; Hansson M
    Biochem Biophys Res Commun; 2010 May; 396(1):46-9. PubMed ID: 20494109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ajuba Preferentially Binds LXRα/RXRγ Heterodimer to Enhance LXR Target Gene Expression in Liver Cells.
    Fan H; Dong W; Li Q; Zou X; Zhang Y; Wang J; Li S; Liu W; Dong Y; Sun H; Hou Z
    Mol Endocrinol; 2015 Nov; 29(11):1608-18. PubMed ID: 26389695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia.
    Kratzer A; Buchebner M; Pfeifer T; Becker TM; Uray G; Miyazaki M; Miyazaki-Anzai S; Ebner B; Chandak PG; Kadam RS; Calayir E; Rathke N; Ahammer H; Radovic B; Trauner M; Hoefler G; Kompella UB; Fauler G; Levi M; Levak-Frank S; Kostner GM; Kratky D
    J Lipid Res; 2009 Feb; 50(2):312-26. PubMed ID: 18812595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.